Cargando…
Current and emerging therapy for the management of vitiligo
Vitiligo is an acquired cutaneous disorder of pigmentation, with an incidence of 0.5% to 2% worldwide. There are three major hypotheses for the pathogenesis of vitiligo that are not exclusive of each other: biochemical/cytotoxic, neural and autoimmune. Recent data provide strong evidence supporting...
Autores principales: | Borderé, Alicia Cecile, Lambert, Jo, van Geel, Nanny |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3047938/ https://www.ncbi.nlm.nih.gov/pubmed/21436965 |
Ejemplares similares
-
Autoimmunity in Segmental Vitiligo
por: Speeckaert, Reinhart, et al.
Publicado: (2020) -
A Review of Non-cultured Epidermal Cellular Grafting in Vitiligo
por: van Geel, Nanja, et al.
Publicado: (2011) -
The use of lasers in vitiligo, an overview
por: Post, N.F., et al.
Publicado: (2022) -
Current Status of Cell-Based Therapies for Vitiligo
por: Domaszewska-Szostek, Anna, et al.
Publicado: (2023) -
Common variants in FOXP1 are associated with generalized vitiligo
por: Jin, Ying, et al.
Publicado: (2010)